← Back to Search

Exercise Prehabilitation for Liver Cancer

N/A
Recruiting
Led By Mohammed Al-Jumayli, MD
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if exercise can help people with liver cancer prepare for surgery better. #Exercise #Cancer #Health

Who is the study for?
This trial is for seniors aged 70 or older who have been diagnosed with bile duct cancer, liver cancer, or liver metastases and are fit enough to exercise. They must be planning to undergo surgery in at least 4 weeks and able to give consent.
What is being tested?
The study is testing an exercise program that includes resistance and aerobic training for senior adults before they go through liver surgery due to hepatobiliary cancers.
What are the potential side effects?
Since the interventions involve physical exercises like resistance and aerobic training, participants may experience muscle soreness, fatigue, or injury related to exercise.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence - Feasibility
Exercise Training Safety
Objective Physical Functioning and Fitness
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Tele Health Exercise PrehabilitationExperimental Treatment2 Interventions
Participants will take part in an exercise program in which they will be encouraged to perform approximately 30 minutes of resistance training exercises approximately twice per week until they undergo surgery (Approximately 2-4 weeks). Participants will also be encouraged to perform moderate aerobic exercise such as brisk walking or using stationary aerobic equipment at least 3 times per week. Participants will wear a FitBit fitness watch to monitor aerobic exercise.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resistance Training
2019
Completed Phase 2
~1230
Aerobic Training
2024
N/A
~880

Find a Location

Who is running the clinical trial?

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
565 Previous Clinical Trials
144,496 Total Patients Enrolled
2 Trials studying Cholangiocarcinoma
49 Patients Enrolled for Cholangiocarcinoma
Mohammed Al-Jumayli, MDPrincipal InvestigatorMoffitt Cancer Center

Media Library

Tele Health Exercise Prehabilitation Clinical Trial Eligibility Overview. Trial Name: NCT05921552 — N/A
Cholangiocarcinoma Research Study Groups: Tele Health Exercise Prehabilitation
Cholangiocarcinoma Clinical Trial 2023: Tele Health Exercise Prehabilitation Highlights & Side Effects. Trial Name: NCT05921552 — N/A
Tele Health Exercise Prehabilitation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05921552 — N/A
~6 spots leftby Jul 2025